SEC Form 3 · accession 0000899243-18-016787
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Brennan
Officer — Chief Commercial Officer
Period of report
Jun 13, 2018
Accepted (ET)
Jun 15, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | holding | — | — | — | 3,094 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common Stock | $3.41 | holding | — | — | — | Jun 13, 2019 | Jun 13, 2025 | Common Stock | 133,333 | — | D |
| Options to purchase Common Stock | $3.41 | holding | — | — | — | Jun 13, 2020 | Jun 13, 2025 | Common Stock | 133,333 | — | D |
| Options to purchase Common Stock | $3.41 | holding | — | — | — | Jun 13, 2021 | Jun 13, 2025 | Common Stock | 133,334 | — | D |